欧盟评估罗伊氏乳杆菌DSM 32203作为狗饲料添加剂的功效

核心提示：2022年7月18日，据欧盟食品安全局（EFSA ）消息，应欧盟委员会要求，欧盟动物饲料添加剂和产品（FEEDAP）研究小组就罗伊氏乳杆菌（Limosilactobacillus reuteri）DSM 32203作为狗饲料添加剂的有效性发表科学意见。……（世界食品网-www.shijieshipin.com）

2022年7月18日，据欧盟食品安全局（EFSA ）消息，应欧盟委员会要求，欧盟动物饲料添加剂和产品（FEEDAP）研究小组就罗伊氏乳杆菌（Limosilactobacillus reuteri）DSM 32203作为狗饲料添加剂的有效性发表科学意见。
部分原文报道如下：

Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the efficacy of Limosilactobacillus reuteri (formerly Lactobacillus reuteri) DSM 32203 as a zootechnical additive for dogs. The additive is a preparation of viable cells of L. reuteri DSM 32203 and it has not been previously authorised as a feed additive in the European Union. The additive is intended for use in complete feed for dogs at a minimum use level of 6 × 109 colony forming units (CFU) per animal and day. In a previous opinion, the FEEDAP Panel could not conclude on the efficacy of L. reuteri DSM 32203 for dogs. The applicant has provided supplementary information to support the efficacy of the additive to dogs. based on the data provided, the FEEDAP Panel concludes that L. reuteri DSM 32203 has the potential to improve faecal consistency by reducing the moisture content of stools from dogs receiving the additive at 1 × 1010CFU/kg feed. However, the Panel has some reservations on the effects in the moisture content of stools, which if maintained over time might cast doubts on the benefits on the long-term use of the additive since it could lead to constipation.